{"id":"NCT02143713","sponsor":"AbbVie","briefTitle":"Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain","officialTitle":"Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05-27","primaryCompletion":"2016-06-22","completion":"2017-05-23","firstPosted":"2014-05-21","resultsPosted":"2018-09-07","lastUpdate":"2021-07-13"},"enrollment":496,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Endometriosis"],"interventions":[{"type":"DRUG","name":"Elagolix","otherNames":["Orilissaâ„¢"]}],"arms":[{"label":"Elagolix 150 mg QD","type":"EXPERIMENTAL"},{"label":"Elagolix 200 mg BID","type":"EXPERIMENTAL"}],"summary":"A randomized study evaluating the continued safety and efficacy of elagolix in the management of moderate to severe endometriosis associated pain in adult pre-menopausal women who completed 6 months treatment in pivotal Study M12-671 (NCT01931670).","primaryOutcome":{"measure":"Percentage of Participants With a Response for Dysmenorrhea at Month 6 Based on Daily Assessment","timeFrame":"Baseline (defined as baseline of Study M12-671 for participants who received elagolix in the pivotal study and baseline of the extension study M12-821 for participants who received placebo in the pivotal study) and Month 6","effectByArm":[{"arm":"Placebo/Elagolix 150 mg QD","deltaMin":37,"sd":null},{"arm":"Placebo/Elagolix 200 mg BID","deltaMin":57.1,"sd":null},{"arm":"Elagolix/Elagolix 150 mg QD","deltaMin":50.8,"sd":null},{"arm":"Elagolix/Elagolix 200 mg BID","deltaMin":75.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29889764","34878624","33963686","32945631","32621325","29476499"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":102},"commonTop":["HOT FLUSH","HEADACHE","NAUSEA","ARTHRALGIA","URINARY TRACT INFECTION"]}}